Physician profile
Roosevelt Offoha
NPI 1700155959
$9,809.61
in general payments reported to CMS, 2019-2025
14 companies · $122 in 2025
The $122 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,635 · 2020: $2,128 · 2021: $1,910 · 2023: $237 · 2024: $3,777 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,861 · Food and Beverage: $1,275.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,860.65 |
| Food and Beverage | $1,275.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $2,626.90 | 2021-2025 | Tlif, Xlif, Tlif Retractor |
| Alphatec Spine, INC | $1,878.19 | 2020-2021 | |
| Nuvasive, INC. | $1,398.71 | 2019-2023 | Tlx, Simplify Cervical Artificial Disc |
| Si-Bone, INC. | $882.44 | 2024-2025 | |
| Centinel Spine, LLC | $780.75 | 2021 | |
| United Orthopedics LLC | $547.41 | 2024 | |
| Surgalign Spine Technologies, INC. | $544.10 | 2020-2021 | |
| Arthrex, INC. | $365.90 | 2024 | |
| Biedermann Motech, INC. | $284.77 | 2019-2020 | |
| Stryker Corporation | $162.54 | 2019-2023 | Accolade |
| Spineology INC. | $152.02 | 2024 | Optimesh Expandable Interbody Fusion System |
| Amplify Surgical, INC. | $144.57 | 2021 | |
| Boston Scientific Corporation | $22.94 | 2023 | Infinion 16 |
| Medtronic USA, INC. | $18.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roosevelt Offoha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.